Clinical Trial Update: Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraoperative imaging with indocyanine green for margin assessment in head and neck squamous cell carcinoma. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Margin Assessment | Phase 2 | Status: RECRUITING